Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
H3 histone pseudogene 30 is a gene annotated in the human genome as part of the histone H3 pseudogene family. Unlike active histone H3 genes, which encode key proteins involved in chromatin structure and function, H3P30 does not produce a functional protein. Pseudogenes are DNA sequences similar to known genes but are typically non-functional due to mutations or lack of regulatory elements[5]. H3P30 is not recognized as a drug target, biomarker, or disease-associated gene and should not be confused with canonical histone H3 variants (such as H3.1 or H3.3), which perform critical roles in chromatin packaging, gene regulation, and epigenetic control[1][3][6]. Note: - The abbreviation "p42" is ambiguous and does not specifically refer to this pseudogene in major scientific databases. Its presence as an alias may be a mistake or misattribution[5]. - This entry should not be used as a target in drug discovery, therapeutic development, or biomarker strategies, as it lacks the protein-coding function and biological relevance found in true histone H3 variants[1][3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on H3 histone pseudogene 30 (H3P30).